Stay updated on Finerenone in HF with LVEF ≥40% Clinical Trial
Sign up to get notified when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.

Latest updates to the Finerenone in HF with LVEF ≥40% Clinical Trial page
- CheckyesterdayChange DetectedThe site revision identifier was updated from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check8 days agoChange DetectedThe FINEARTS-HF record is available with details on the completed Phase 3 finerenone-versus-placebo heart-failure study, including its outcomes, eligibility criteria, participating locations, results, publications, and study documents.SummaryDifference100%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe site revision label changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedA site-wide NIH notice appears above the ClinicalTrials.gov page, announcing updates about terminology used during a transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check36 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check43 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to Finerenone in HF with LVEF ≥40% Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.